Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.

A bispecific mouse monoclonal antibody (mAb) that recognises carcinoembryonic antigen (CEA) with one binding site and vinblastine (VLB) with the other was used, and its in vivo immunosuppressive effect specific for anti-mouse immunoglobulin (Ig) was studied. The antibody was incubated with VLB at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivolapenko, G. B., Moreno, C., Smith, W., Corválan, J., Ritter, M. A., Epenetos, A. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977510/
https://www.ncbi.nlm.nih.gov/pubmed/1892756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977510/
https://www.ncbi.nlm.nih.gov/pubmed/1892756

Ejemplares similares